These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7164268

  • 1. In vivo activity of microbial heparinase.
    Langer R, Linhardt RJ, Larsen AK, Cooney CL, Tapper D, Klein M.
    Trans Am Soc Artif Intern Organs; 1982; 28():387-90. PubMed ID: 7164268
    [No Abstract] [Full Text] [Related]

  • 2. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD, Drongowski RA, Linhardt RJ, Cooney CL, Langer RS.
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [Abstract] [Full Text] [Related]

  • 3. Determination of the intrinsic Michaelis constant of immobilized heparinase.
    Lortie R, Broughton R.
    Ann N Y Acad Sci; 1995 Mar 31; 750():58-61. PubMed ID: 7785881
    [No Abstract] [Full Text] [Related]

  • 4. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.
    Yang VC, Bernstein H, Cooney CL, Kadam JC, Langer R.
    Thromb Res; 1986 Dec 01; 44(5):599-610. PubMed ID: 3810562
    [Abstract] [Full Text] [Related]

  • 5. Heparinase immobilization. Characterization and optimization.
    Yang VC, Bernstein H, Langer R.
    Ann N Y Acad Sci; 1988 Dec 01; 542():515-20. PubMed ID: 3228243
    [No Abstract] [Full Text] [Related]

  • 6. Mode of action of heparin lyase on heparin.
    Linhardt RJ, Fitzgerald GL, Cooney CL, Langer R.
    Biochim Biophys Acta; 1982 Apr 03; 702(2):197-203. PubMed ID: 7082675
    [Abstract] [Full Text] [Related]

  • 7. Effect of extracorporeal enzymatic deheparinization on formed blood components.
    Larsen AK, Linhardt RJ, Tapper D, Klein M, Langer R.
    Artif Organs; 1984 May 03; 8(2):198-203. PubMed ID: 6732548
    [Abstract] [Full Text] [Related]

  • 8. An immobilized microbial heparinase for blood deheparinization.
    Linhardt RJ, Cooney CL, Tapper D, Zannetos CA, Larsen AK, Langer R.
    Appl Biochem Biotechnol; 1984 Feb 03; 9(1):41-55. PubMed ID: 6476820
    [Abstract] [Full Text] [Related]

  • 9. A comparative analysis of the primary sequences and characteristics of heparinases I, II, and III from Flavobacterium heparinum.
    Godavarti R, Sasisekharan R.
    Biochem Biophys Res Commun; 1996 Dec 24; 229(3):770-7. PubMed ID: 8954971
    [Abstract] [Full Text] [Related]

  • 10. Heparinase I from Flavobacterium heparinum. Identification of a critical histidine residue essential for catalysis as probed by chemical modification and site-directed mutagenesis.
    Godavarti R, Cooney CL, Langer R, Sasisekharan R.
    Biochemistry; 1996 May 28; 35(21):6846-52. PubMed ID: 8639636
    [Abstract] [Full Text] [Related]

  • 11. Immuno-affinity purification of heparinase.
    Linhardt RJ, Merchant ZM, Persinger DW.
    Int J Biochem; 1985 May 28; 17(11):1179-83. PubMed ID: 3908184
    [Abstract] [Full Text] [Related]

  • 12. Specific plate assay for bacterial heparinase.
    Zimmermann JJ, Langer R, Cooney CL.
    Appl Environ Microbiol; 1990 Nov 28; 56(11):3593-4. PubMed ID: 2268165
    [Abstract] [Full Text] [Related]

  • 13. Heparinase-II-catalyzed degradation of N-propionylated heparin.
    Moffat CF, Long WF, McLean MW, Williamson FB.
    Arch Biochem Biophys; 1997 Feb 15; 338(2):201-6. PubMed ID: 9028872
    [Abstract] [Full Text] [Related]

  • 14. Immobilized heparin lyase system for blood deheparinization.
    Bernstein H, Yang VC, Cooney CL, Langer R.
    Methods Enzymol; 1988 Feb 15; 137():515-29. PubMed ID: 3374357
    [No Abstract] [Full Text] [Related]

  • 15. Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.
    Linhardt RJ, Grant A, Cooney CL, Langer R.
    J Biol Chem; 1982 Jul 10; 257(13):7310-3. PubMed ID: 7085627
    [Abstract] [Full Text] [Related]

  • 16. Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli.
    Godavarti R, Davis M, Venkataraman G, Cooney C, Langer R, Sasisekharan R.
    Biochem Biophys Res Commun; 1996 Aug 23; 225(3):751-8. PubMed ID: 8780685
    [Abstract] [Full Text] [Related]

  • 17. Activation of a heparin-degrading enzyme by a 'protein matrix' effect.
    Khan MY, Leonard CM, Newman SA.
    Biochem Mol Biol Int; 1993 Jul 23; 30(3):579-87. PubMed ID: 8401315
    [Abstract] [Full Text] [Related]

  • 18. Sulfur regulation of heparinase and sulfatases in Flavobacterium heparinum.
    Cerbelaud EC, Conway LJ, Galliher PM, Langer RS, Cooney CL.
    Appl Environ Microbiol; 1986 Mar 23; 51(3):640-6. PubMed ID: 3963813
    [Abstract] [Full Text] [Related]

  • 19. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
    van den Besselaar AM, Meeuwisse-Braun J.
    Blood Coagul Fibrinolysis; 1993 Aug 23; 4(4):635-8. PubMed ID: 8218862
    [Abstract] [Full Text] [Related]

  • 20. Substrate specificity of the heparin lyases from Flavobacterium heparinum.
    Desai UR, Wang HM, Linhardt RJ.
    Arch Biochem Biophys; 1993 Nov 01; 306(2):461-8. PubMed ID: 8215450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.